Mike Polark
Stock Analyst at Wolfe Research
(3.33)
# 1,011
Out of 5,008 analysts
75
Total ratings
50%
Success rate
4.39%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Upgrades: Peer Perform | n/a | $98.43 | - | 3 | Jun 30, 2025 | |
| BBNX Beta Bionics | Initiates: Outperform | $20 | $21.95 | -8.88% | 1 | May 30, 2025 | |
| LIVN LivaNova | Upgrades: Outperform | $60 | $52.63 | +14.00% | 9 | May 20, 2025 | |
| PODD Insulet | Upgrades: Outperform | $350 | $311.69 | +12.29% | 4 | May 13, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $230 → $236 | $76.37 | +209.02% | 7 | May 6, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $133 → $150 | $175.75 | -14.65% | 8 | May 2, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $25.03 | +15.86% | 1 | Mar 31, 2025 | |
| EW Edwards Lifesciences | Downgrades: Underperform | $60 | $76.56 | -21.63% | 4 | Jan 16, 2025 | |
| RMD ResMed | Downgrades: Underperform | $180 | $281.38 | -36.03% | 5 | Sep 18, 2024 | |
| ZBH Zimmer Biomet Holdings | Initiates: Peer Perform | n/a | $98.83 | - | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $405 | $366.28 | +10.57% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $487 → $503 | $449.69 | +11.85% | 7 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $133.74 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $127.71 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $66.36 | +82.34% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $15.01 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $16.22 | +54.13% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $148.13 | +11.39% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $96.70 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $10.77 | +20.71% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $5.80 | +262.07% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $240.64 | +3.89% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $1.86 | +2,211.83% | 1 | Sep 2, 2020 |
Medtronic
Jun 30, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $98.43
Upside: -
Beta Bionics
May 30, 2025
Initiates: Outperform
Price Target: $20
Current: $21.95
Upside: -8.88%
LivaNova
May 20, 2025
Upgrades: Outperform
Price Target: $60
Current: $52.63
Upside: +14.00%
Insulet
May 13, 2025
Upgrades: Outperform
Price Target: $350
Current: $311.69
Upside: +12.29%
Inspire Medical Systems
May 6, 2025
Maintains: Outperform
Price Target: $230 → $236
Current: $76.37
Upside: +209.02%
iRhythm Technologies
May 2, 2025
Maintains: Outperform
Price Target: $133 → $150
Current: $175.75
Upside: -14.65%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $25.03
Upside: +15.86%
Edwards Lifesciences
Jan 16, 2025
Downgrades: Underperform
Price Target: $60
Current: $76.56
Upside: -21.63%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $281.38
Upside: -36.03%
Zimmer Biomet Holdings
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $98.83
Upside: -
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $366.28
Upside: +10.57%
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $449.69
Upside: +11.85%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $133.74
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $127.71
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $66.36
Upside: +82.34%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $15.01
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $16.22
Upside: +54.13%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $148.13
Upside: +11.39%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $96.70
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $10.77
Upside: +20.71%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $5.80
Upside: +262.07%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $240.64
Upside: +3.89%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $1.86
Upside: +2,211.83%